(Q33949202)

30 July 2017

In vivo molecular target assessment of matrix metalloproteinase inhibition (English)

1 reference

30 July 2017

Bremer C

1

1 reference

30 July 2017

Tung CH

series ordinal

2

1 reference

30 July 2017

Weissleder R

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

30 July 2017

1 reference

30 July 2017

7

1 reference

30 July 2017

743-748

1 reference

30 July 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/89126

30 July 2017

0 references

cites work

In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion

1 reference

7 January 2021

Changing views of the role of matrix metalloproteinases in metastasis

1 reference

7 January 2021

Molecular regulation, membrane association and secretion of tumor cathepsin B.

1 reference

7 January 2021

Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications

1 reference

7 January 2021

Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model

1 reference

7 January 2021

Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed

1 reference

7 January 2021

Design and therapeutic application of matrix metalloproteinase inhibitors

1 reference

7 January 2021

Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials

1 reference

7 January 2021

Clinical studies with matrix metalloproteinase inhibitors

1 reference

7 January 2021

Matrix metalloproteinases: biologic activity and clinical implications

1 reference

7 January 2021

Tumor targeting with a selective gelatinase inhibitor

1 reference

7 January 2021

Preclinical and clinical studies of MMP inhibitors in cancer

1 reference

7 January 2021

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.

1 reference

7 January 2021

Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.

1 reference

7 January 2021

Experimental models to identify antimetastatic drugs: are we there yet? A position paper

1 reference

7 January 2021

Ala-Pro-cresyl violet, a synthetic fluorogenic substrate for the analysis of kinetic parameters of dipeptidyl peptidase IV (CD26) in individual living rat hepatocytes

1 reference

7 January 2021

Heterogeneous suppression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B

1 reference

7 January 2021

In vivo imaging of tumors with protease-activated near-infrared fluorescent probes

1 reference

7 January 2021

Antibody-mediated versus nontargeted delivery in a human small cell lung carcinoma model

1 reference

7 January 2021

Substrate specificity of the human matrix metalloproteinase stromelysin and the development of continuous fluorometric assays

1 reference

7 January 2021

Overview of matrix metalloproteinase expression in cultured human cells

1 reference

7 January 2021

A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases

1 reference

7 January 2021

Preclinical evaluation and phase I clinical trial of a 99mTc-labeled synthetic polymer used in blood pool imaging

1 reference

7 January 2021

Near-infrared images using continuous, phase-modulated, and pulsed light with quantitation of blood and blood oxygenation

1 reference

7 January 2021

Near-infrared optical imaging of protease activity for tumor detection

1 reference

7 January 2021

Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement

1 reference

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

7 January 2021

Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis

1 reference

7 January 2021

Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration.

1 reference

7 January 2021

A continuous fluorescence-based assay of human cytomegalovirus protease using a peptide substrate

1 reference

7 January 2021

Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): possible involvement in neurodegenerative processes

1 reference

7 January 2021

Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging

1 reference

7 January 2021

Identifiers

DOI

10.1038/89126

1 reference

30 July 2017

1 reference